Steris (STE) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
STERIS (STE) PT Lowered to $248 at Needham & Company
May 12, 2022 12:46 PM EDTNeedham & Company analyst Mike Matson lowered the price target on STERIS (NYSE: STE) to $248.00 (from $263.00) while maintaining a Buy rating following earnings.
The analyst commented, "STE's F4Q22 revenue and EPS beat consensus. Organic revenue growth improved from the prior quarter overall and in all... More
